Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of ombitasvir/paritaprevir/ritonavir-based therapy in HCV patients with chronic kidney disease.
El-Sayed M, Elserafy M, El Raziky M, Elakel W, Saad Y, Fayad T, Korany M, Mehrez M, Salama R, Mahrous M, Zaki A, Hassany M, Ammar I, Elsaeed K, Elshazly Y, Doss W. El-Sayed M, et al. Among authors: el raziky m. Arab J Gastroenterol. 2023 Feb;24(1):29-33. doi: 10.1016/j.ajg.2022.10.001. Epub 2023 Feb 20. Arab J Gastroenterol. 2023. PMID: 36813580
Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients.
Eletreby R, Elakel W, Said M, El Kassas M, Seif S, Elbaz T, El Raziky M, Abdel Rehim S, Zaky S, Fouad R, Gamal Eldeen H, Abdo M, Korany M, Yosry A, El Serafy M, El-Sayed MH, ElShazly Y, Waked I, Doss W, Esmat G. Eletreby R, et al. Among authors: el kassas m, el sayed mh, el serafy m, el raziky m. Liver Int. 2017 Apr;37(4):534-541. doi: 10.1111/liv.13266. Epub 2016 Nov 4. Liver Int. 2017. PMID: 27712017
Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: Lessons from the Egyptian experience.
Elsharkawy A, El-Raziky M, El-Akel W, El-Saeed K, Eletreby R, Hassany M, El-Sayed MH, Kabil K, Ismail SA, El-Serafy M, Abdelaziz AO, Shaker MK, Yosry A, Doss W, El-Shazly Y, Esmat G, Waked I. Elsharkawy A, et al. Among authors: el sayed mh, el saeed k, el serafy m, el raziky m, el akel w, el shazly y. J Hepatol. 2018 Apr;68(4):691-698. doi: 10.1016/j.jhep.2017.11.034. Epub 2017 Dec 6. J Hepatol. 2018. PMID: 29223371
High SVR rate following retreatment of non-sustained virological responders to sofosbuvir based anti-HCV therapies regardless of RAS testing: A real-life multicenter study.
Darweesh SK, Elsaeed K, Omar H, El Raziky M, Elakel W, Elserafy M, Ismail SA, Gomaa AA, Mehrez M, El Kassas M, Abdullah M, Shaker MK, Esmat G, El Shazly Y, Doss W, Waked I. Darweesh SK, et al. Among authors: el raziky m. Expert Rev Gastroenterol Hepatol. 2019 Sep;13(9):907-914. doi: 10.1080/17474124.2019.1629287. Epub 2019 Jun 23. Expert Rev Gastroenterol Hepatol. 2019. PMID: 31173527
Hepatitis C genotype 4 with normal transaminases: correlation with fibrosis and response to treatment, a cohort Egyptian study of 4277 patients.
Abdel-Rahman M, Saad Y, El-Raziky M, Zayed N, El-Akel W, Said M, El-Beshlawy M, Esmat G. Abdel-Rahman M, et al. Among authors: el beshlawy m, el raziky m, el akel w. Clin Res Hepatol Gastroenterol. 2013 Nov;37(5):479-84. doi: 10.1016/j.clinre.2013.02.009. Epub 2013 Mar 26. Clin Res Hepatol Gastroenterol. 2013. PMID: 23540379
Impact of vitamin D supplementation on sustained virological response in chronic hepatitis C genotype 4 patients treated by pegylated interferon/ribavirin.
Esmat G, El Raziky M, Elsharkawy A, Sabry D, Hassany M, Ahmed A, Assem N, El Kassas M, Doss W. Esmat G, et al. Among authors: el kassas m, el raziky m. J Interferon Cytokine Res. 2015 Jan;35(1):49-54. doi: 10.1089/jir.2014.0060. Epub 2014 Jul 25. J Interferon Cytokine Res. 2015. PMID: 25061714 Clinical Trial.
Retreatment of chronic hepatitis C virus genotype-4 patients after non-structural protein 5A inhibitors' failure: efficacy and safety of different regimens.
El-Khayat H, Kamal EM, Mahmoud H, Gomaa A, Ebeid B, Sameh Y, Hasseb A, El Raziky M, El Serafy M, Doss W, Esmat G, Fouad Y, Attia D. El-Khayat H, et al. Among authors: el raziky m. Eur J Gastroenterol Hepatol. 2020 Mar;32(3):440-446. doi: 10.1097/MEG.0000000000001581. Eur J Gastroenterol Hepatol. 2020. PMID: 31688311
87 results